Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Pre-Tax Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+37.8%
Studio
Year-over-Year Change

Pre-tax income as a percentage of revenue

3Y CAGR
+37.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM13.12%+253.5%
2024-8.54%-38.6%
2023-6.16%-223.0%
20225.01%+101.2%
2021-406.13%-
20200.00%-
20190.00%-